These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9797891)

  • 1. Tinzaparin as an antithrombotic: an overview.
    Fegan CD
    Hosp Med; 1998 Feb; 59(2):145-8. PubMed ID: 9797891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
    Faivre R; Neuhart E; Mirshahi M; Mirshahi M; Soria C; Soria J; Bassand JP; Caen JP; Maurat JP
    Semin Thromb Hemost; 1989 Oct; 15(4):435-9. PubMed ID: 2554504
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin and pulmonary embolism.
    Nardini S
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):247-9. PubMed ID: 8766203
    [No Abstract]   [Full Text] [Related]  

  • 4. Tinzaparin: new indication. Easier treatment of less severe pulmonary embolism.
    Prescrire Int; 2002 Feb; 11(57):13-5. PubMed ID: 11985368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant and antithrombotic therapy in deep venous thrombosis and pulmonary embolism.
    Stein PD
    Henry Ford Hosp Med J; 1988; 36(1):35-40. PubMed ID: 3294212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.
    Simonneau G; Sors H; Charbonnier B; Page Y; Laaban JP; Azarian R; Laurent M; Hirsch JL; Ferrari E; Bosson JL; Mottier D; Beau B
    N Engl J Med; 1997 Sep; 337(10):663-9. PubMed ID: 9278462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.
    Friedel HA; Balfour JA
    Drugs; 1994 Oct; 48(4):638-60. PubMed ID: 7528134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 11. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting.
    Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19882795
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic strategy in venous thromboembolic disease (VTD)].
    Arch Bronconeumol; 1994 Dec; 30(10):498-505. PubMed ID: 7827764
    [No Abstract]   [Full Text] [Related]  

  • 15. Respiratory pharmacology. Antithrombotic and fibrinolytic therapy.
    Watson-Williams EJ
    Clin Chest Med; 1986 Sep; 7(3):469-80. PubMed ID: 3533402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation in patients with venous thromboembolism].
    Rüfer A; Wuillemin WA
    Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinzaparin thromboprophylaxis prescribing practice after caesarean delivery 2009-2014.
    Maguire PJ; McGuire M; Power KA; McNicholl M; Sheehan SR; Turner MJ
    Ir J Med Sci; 2018 Feb; 187(1):123-126. PubMed ID: 28474237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy for venous thromboembolism.
    Hyers TM
    Clin Chest Med; 1984 Sep; 5(3):479-86. PubMed ID: 6386292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.
    Raskob GE
    Curr Opin Pulm Med; 1999 Jul; 5(4):216-21. PubMed ID: 10407690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.